Furthermore, macrophages isolated from patients with NLRC4 mutations (Thr337Ser) release more IL-18 upon activation than macrophages from patients with NOMID, suggesting that the enhanced IL-18 signalling is contributing to cytokine storms and the development of MAS [67]. The gene discussed is NLRC4; the disease is macrophage activation syndrome.